Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
10.55041/IJSREM.ISTCESD031
Volume:
10 |
9 |
Sep 2026
Pages:
1-5
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
INDEPENDENT RESEARCHER
Indira Gandhi (Sr.) College CIDCO Nanded
Kidney stone formation depends on urinary volume, concentrations of calcium, phosphate, oxalate, sodium cystine and uric acid ions, concentrations of natural calculi inhibitors and urine pH (Menon and Resnick 2002). Kidney stones occur in gout, hypercalciuria, hyperparathyroidism, renal tubular acidosis and certain inherited metabolic condition like cystinuria and hyperoxaluria (Gilhotra et al., 2013). Stone formation is one of the painful urologic disorders which occur in approximately 12% of the global population and its re-occurrence rate in males is 70%-81% and 47%-60% in female (Soundararajan et al., 2006). It is reported that the level of contribution by different risk factors to stones formation varies among different populations. Many patients reportedly had more than one risk factor (Mute V.S., 2012). Herbal medicines are in vogue (Isaacs, 2010). Herbalists narrated that the patients having kidney stones generally experience sudden acute pain. Acute pain is due to the blocking in the urinary tract; the symptom starts with incessant vomiting (Stamatelou et al., 2003; Schoenstadt, 2008). The incidence of urinary stones has been increasing over the last years, while the age of onset is decreasing (Moe, 2006). The medical administration of urolithiasis includes the surgical removal of stones. Among the treatments exercised are Extracorporeal Shock Wave Lithotripsy and drug treatment and surgical procedures such as ureteronoscopy (URS) or percutaneous nephrolithotomy (PCNL) and the combination of these techniques (Gurocak and Kupeli, 2006). The high cost, compelling data now a days suggest that the exposure to shock waves in therapeutic doses may cause decrease in renal function. Management of stone disease depends on the size of calculi, severity of symptoms, degree of obstruction, kidney function, location of the stones and the presence or absence of associated infection influence the choice of one type of intervention over the other. Currently this serious problem can be treated with increased fluid intake, medications like thiazides, allopurinol (Atmani, 2003) and potassium citrate (Tracy and Pearle, 2009) for reducing urinary saturation of stone forming calcium salts, diuretics for facilitating urine flow. In spite of substantial improvement in the pathophysiology and treatment of urolithiasis, there is no satisfactory drug offered for use in clinical therapy. Indian medicine recommends numerous medicinal plants and exploits large number of plant drugs as ancient times to treat urinary stones. Ayurveda offers vast scope for the successful treatment of urolithiasis (Satish et al., 2009). Herbal remedy may help to prevent, dissolve and expel kidney stones naturally. The Ayurvedic literature claims countless plants to be useful in urinary stones; even many plants need to be exploited for their pharmacological actions (Prasad, 2007).As a results, the search for antilithiatic drugs from natural sources has assumed superior importance.
KEYWORDS
The % Inhibition of Calcium Oxalate Crystal aggregation by Chenopodium album L. (Leaf) was studied and It is interesting to note that water and ethanolic extracts showed positive results in the percent aggregation of inhibition and 400 and 500 µg/ml concentrations of chloroform extracts also showed the positive results. 500 µg/ml concentration of water extract showed highest in the percent aggregation of inhibition The % Inhibition of Calcium Oxalate Crystal aggregation by Abutilon indicum L. (Leaf) was studied and the water extracts in all the test concentrations showed the positive results in percent aggregation of inhibition.
Menon, M. and Resnick, M.I. (2002) Urinary lithiasis: Etiology, diagnosis and medical management. In: Walsh, P.C., Ed., Campbell’s Urology, Saunder’s, 4, 3229-3305. Gilhotra Umesh Kumar, Govind Mohan, A.J.M. Christina (2013). Antilithiatic activity of poly-herbal formulation tablets by in-vitro method. J App Pharm Sci,; 3 (05): 043-048. Soundararajan P, Mahesh R, Ramesh T, Hazeena Begum V. (2006). Effect of Aerva Lanata on calcium oxalate urolithiasis in rats. Indian journal of experimental biology, 44, 981-986. 2. Mute V.S., 2012 Isaacs, 2010 Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003 May;63(5):1817-23. Moe, O.W. (2006) Kidney Stones: Pathophysiology and Medical Management. Lancet, 367, 333-344. Schoenstadt, A. (2008). Adult ADHD to Albuterol Solution. eMedTV Sitemap. Gürocak S, Küpeli B. Consumption of historical and current phytotherapeutic agents for urolithiasis: a critical review. J Urol. 2006 Aug;176(2):450-5. Atmani F. Medical management of urolithiasis, what opportunity for phytotherapy? Front Biosci. 2003 May 1;8:s507-14. Tracy CR, Pearle MS. Update on the medical management of stone disease. Curr Opin Urol. 2009 Mar;19(2):200-4.
Publication Date
9/29/2026
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
0
Total views since publication
PDF Downloads
3
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...